#FreeChangsha3: Wrongfully Detained HIV/Viral Hepatitis Activists

Three Chinese lawyers and advocates, Cheng Yuan, Wu Gejianxiong, and Liu Yongze, who work on employment discrimination and disability justice for people living with HIV and viral hepatitis, have been wrongfully detained in Hunan, China since 22 July 2019. More
WE NEED A COMPREHENSIVE HEPATITIS C PACKAGE OF SERVICES FOR PEOPLE WHO USE AND INJECT DRUGS! “It’s been more than 5 years since we cured hepatitis C...where’s my package?”

Achieving hepatitis C virus (HCV) elimination by 2030 depends on how countries fund prevention, testing, treatment, and care and how they include HCV in efforts for universal health coverage. (...) More
Have a heart, save my liver! Where are my diagnostics?

Of the 71 million people living with chronic hepatitis C, only ≈20% are aware of their status and less than 5% of people living in LMICs have been diagnosed.
We need simpler & cheaper tests to scale up diagnosis! More
Hepatitis C cure, sofosbuvir, turns 5 years old: The vast majority of people still have not been treated

Advocates scandalized that Gilead’s hepatitis C profits have raked in US$25.8 billion, which could have treated everyone while still earning US$16 billion in profits. 6 December 2018, Paris, (...) More
Dying at these prices: Generic HCV cure denied mapCrowd report #2

To mark the significance of World Hepatitis Day, Médecins du Monde (MdM) and Treatment Action Group (TAG) have produced a new report Dying at these prices: Generic HCV cure denied, based on crowdsourced hepatitis C data from over 40 countries available at mapCrowd.org. More

Recent publications

AFRICAN DECLARATION TO ELIMINATE HEPATITIS C AND IMPROVE THE HEALTH OF PEOPLE WHO USE DRUGS Cape Town, South Africa, 20 February 2020

If your organization would like to sign on, please contact INHSU: info@inhsuafrica2020.com
We, the community of people working to eliminate hepatitis C in the African region express alarm regarding the increasing impact of drug use, hepatitis C, and other viral co-infections (including HIV and (...) More
21 February 2020
ACCESS TO HEPATITIS C TREATMENT AND CARE AMONG PEOPLE WHO INJECT DRUGS: FAILING PEOPLE MOST DISPROPORTIONATELY AFFECTED ISSUE BRIEF

Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans. There is scarce information about how people who inject drugs (PWID) are factored into national (...) More
2 February 2020
WHO HAS ACCESS TO HEPATITIS C TESTING? LIBERATE OUR DIAGNOSTICS! ISSUE BRIEF

Accurate, high-quality data on the hepatitis C virus (HCV) continues to be a struggle for countries that are scaling up testing services and linking people to treatment and care, as part of implementing their national hepatitis plans. There is very little in-country information about the (...) More
24 January 2020
Activist Guide to Hepatitis C Virus Diagnostics

Out Now! A NEW Activist Guide to Hepatitis C Virus (HCV) Diagnostics is to provide information for you and your community. The Activist Guide aims to provide a deeper focus on diagnosis with updated information about the steps and different technologies involved in diagnosing a person with (...) More
31 October 2019
Strengthening Advocacy for Hepatitis C Diagnostics: Malaysia Workshop Summary Report

1-3 March 2019, Penang, Malaysia
Positive Malaysian Treatment Access and Advocacy Group (MTAAG+), with partners Treatment Action Group and the Foundation for Innovative New Diagnostics, convened the first advocacy workshop on hepatitis C virus (HCV) diagnostics. The workshop presented the (...) More
14 June 2019